41 |
The role of integrin mediated cell adhesion in angiopoietin-1 and angiopoietin-2 biology /Carlson, Timothy Ryan. January 2003 (has links)
Thesis (Ph. D.)--University of Chicago, Committee on Human Nutrition and Nutritional Biology, June 2003. / Includes bibliographical references. Also available on the Interet.
|
42 |
Skeletal tissue proteins isolation and characterization of novel extracellular matrix proteins /Wendel, Mikael. January 1994 (has links)
Thesis (doctoral)--Lunds Universitet, 1994. / Added t.p. with thesis statement inserted. Includes bibliographical references.
|
43 |
Exploring the Role of Human Endogenous Retroviral Gag in the Formation and Content of Extracellular VesiclesMcCulloch, Danielle 30 August 2018 (has links)
Human Endogenous Retroviruses (HERV) are derived from exogenous retroviruses that infected inheritable germline tissues millions of years ago and account for 8% of the human genome. Like other retroviruses HERVs encode Gag, Pol and sometimes Env proteins. During a retroviral infection, retroviral Gag recruits the hosts Endosomal Sorting Complex Required for Transport (ESCRT) and associated proteins (ALIX and TSG101) to produce precisely sized viruses from endosomes or the plasma membrane. The ESCRT machinery is also involved in cytokinesis and control growth factor receptor signalling. HERV-K is the most recent HERV family to insert into the genome and is still able to produce mostly intact transcripts, including Gag. When expressed, Gag causes cells to release Virus-Like Particles (VLP) that lack HERV genomes. These retroviral VLP are remarkably similar to a sub-category of extracellular vesicles (EVs) called exosomes. Exosomes require ALIX, TSG101 and the ESCRT machinery for their production. It is possible that HERV-K Gag is required for exosome production or that HERV VLPs are a major contaminant of exosome preparations that account for many of the functions attributed to exosomes. Our data shows that HERV-K Gag over-expression or knockdown did not change the number of EVs released per cell in two cell lines. As well there was no difference in the amount of ALIX and TSG101 in the EVs in these conditions. The most intriguing observation made was the increase of cell number with expression of HERV-K Gag and decrease when HERV-K Gag was knocked down in HEK293T. We are currently unable to conclude the role of HERV-K Gag on EV production and content. We speculate that HERV-K Gag might affect cells through controlling cell proliferation or death, for example by competing with ESCRT machinery to impact signalling through growth factor receptors. This study begins to outline the potential effects HERV-K Gag might have on EV release and cell proliferation.
|
44 |
Role of extracellular vesicles in development of antiandrogen resistance in prostate cancerJanuary 2018 (has links)
acase@tulane.edu / 1 / Adedoyin Johnson
|
45 |
LOXL4 Is a Selectively Expressed Candidate Diagnostic Antigen in Head and Neck CancerWeise, Jan, Rudolph, Pierre, Heiser, Axel, Kruse, Marie Luise, Hedderich, Jürgen, Cordes, Christian, Hoffmann, Markus, Brant, Ommo, Ambrosch, Petra, Csiszar, Katalin, Görögh, Tibor 01 June 2008 (has links)
Selective up-regulation of the mRNA of LOXL4, a member of the LOX matrix amine oxidase family, significantly correlated with lymph node metastases and higher tumour stages in head and neck squamous cell carcinomas (HNSCC). To evaluate the diagnostic and prognostic value of the protein we produced an antibody specific for LOXL4 and assessed the expression in 317 human HNSCC specimens. The LOXL4 protein was detected in 92.7% of primary tumours, in 97.8% of lymph node metastases and in affected oral mucosa with high-grade dysplasia, but was absent in various non-neoplastic tissues of the head and neck. TNM categories and overall survival did not link to grades of immunoreactivity. Studies in cultured primary hypopharyngeal HTB-43 carcinoma cells detected perinuclear and cell surface expression of LOXL4, but no nuclear localisation. Therefore, its interactive SRCR-domains and catalytic activity combined with tumour cell specific expression and cell surface associated location indicate multiple functions in tumour cell adhesion and interactions with the extracellular matrix. Our data suggest that LOXL4 is useful both as tumour marker and target in the treatment of HNSCC.
|
46 |
Mechanisms and Therapeutic Applications of RNA Delivery by Small Extracellular VesiclesReshke, Ryan 06 June 2023 (has links)
No description available.
|
47 |
THE ROLE OF EXTRACELLULAR VESICLES IN BREAST CANCER PROGRESSION AND DIAGNOSISPlatko, Khrystyna January 2016 (has links)
Breast cancer (BC) is the second most commonly occurring malignant disease in
women and one of the leading causes of cancer-related death worldwide, globally
accounting for almost half-a-million deaths per year. In Canada, BC is the second leading
cause of death in women preceded only by lung cancer. Invasion and metastasis are the
most common causes of mortality in patients with BC. Studies show that extracellular
vesicles (EVs) play an important role in immune system evasion, invasion and metastasis.
Studies have shown a significant elevation of EVs in the serum of cancer patients
compared to healthy subjects. Furthermore, elevated secretion of EVs has been correlated
with cancer malignancy. Therefore, it has been suggested that EVs may be an important
non-invasive diagnostic and prognostic tool for cancer. Herein our in vitro studies show
that ER-α is secreted via EVs from MCF-7 cells. Furthermore, our mass spectrometry
(MS)-based proteomic study showed that the proteomic profile of EVs from the plasma of
BC patients differs from that of healthy subjects. In addition, we have also shown that
vesicular abundance of proteins associated with tumour malignancy, such as tissue factor
(TF), plasminogen activator inhibitor (PAI-1), a disintegrin and metalloproteinase 12
(ADAM12) and β-Catenin is different between primary tumour and metastatic disease. / Thesis / Master of Science (MSc)
|
48 |
Investigating the Extracellular Matrix in Pulmonary Fibrosis / INVESTIGATING THE EXTRACELLULAR MATRIX’S ROLE IN PULMONARY FIBROSIS TO APPROPRIATELY MODEL DISEASE AND TEST ANTIFIBROTIC THERAPIESUpagupta, Chandak January 2019 (has links)
IPF is a progressive disease, characterized by dysregulated fibrosis of the extracellular matrix (ECM). The pathobiology of the disease is still unknown, and the median survival post-diagnosis is about 3-5 years. The two current US FDA approved drugs for IPF (nintedanib and pirfenidone) slow, but fail to reverse, disease progression.
There is cumulating research that suggests the ECM is an active player in fibrosis. In this thesis, we summarized the current knowledge of ECM-cell interactions in the context of pulmonary fibrosis. To gain more mechanistic insight into the ECM characteristics that dictate cell behavior, we established a 3D ECM ex vivo system to assess the nonfibrotic and fibrotic ECM’s effect on fibroblasts. The ECM appears to promote both pathological and physiological cellular changes, depending on its structural and compositional properties. We also used this 3D ex vivo system as a preclinical tool to test the effect of directly inhibiting mechanotransduction in the fibrotic ECM – fibroblast profibrotic relationship. Lastly, since the fibrotic ECM seems to play a key role in progressive fibrosis, we evaluate if researchers are appropriately using the bleomycin model by starting interventions after ECM fibrosis is established. Over the past decade in the field, there has been an overall improvement in the appropriate therapeutic timing. In the preventative studies, however, there is still an inadequate characterization of inflammation. There is also poor transparency of preclinical-bleomycin data for clinically tested interventions for IPF. Addressing these shortcomings may improve the utility of the model at predicting an intervention’s success in clinical trials.
These findings illustrate the ECM’s role in driving pulmonary fibrosis. Therefore, the ECM should be further investigated to understand disease progression, and reproduced in preclinical models to test interventions. This will improve the transition of pathobiological findings into efficient drug development for this devastating disease. / Thesis / Candidate in Philosophy / Idiopathic pulmonary fibrosis (IPF) (idiopathic - unknown cause; pulmonary - lungs; fibrosis - scarring) is characterized by progressive scarring of the lung extracellular matrix (ECM). The ECM is an organ’s backbone that provides structural and biochemical support to surrounding cells. Continued ECM scarring can lead to difficulty breathing, cough, and ultimately death. The cause of IPF is unknown, however, studies suggest that the scarred ECM can promote further scarring, and cause disease progression. In this thesis, we summarized the current knowledge of how the ECM interacts with cells. Using a 3D model we see that depending on the ECM’s structure and composition, it can promote both disease and healthy cellular changes. Lastly, we evaluate if researchers are appropriately using the bleomycin model (most common preclinical model for pulmonary fibrosis) by testing interventions after ECM fibrosis is established. We propose changes to improve its usefulness as a preclinical tool for IPF.
|
49 |
The role of hemocytes in formation of the cardiac extracellular matrixMacDuff, Danielle January 2019 (has links)
Cardiovascular disease is a leading cause of death worldwide. Changes in the cardiac extracellular matrix (ECM) are associated with cardiac pathologies such as cardiomyopathy and cardiac hypertrophy. The ECM is a dynamic scaffold of proteoglycans, fibrous proteins, and glycoproteins that sheathes and protects many organs and tissues, including the heart, by attenuating mechanical stress. Misregulation of ECM proteins triggers changes in matrix stiffness, which can lead to age-associated and congenital heart defects. ECM rigidity is also important to the migration of cells, such as hemocytes, the invertebrate blood cells. In the embryo, hemocytes also perform fibroblast functions, through the deposition of the ECM proteins Collagen and Laminin. Hemocytes are hypothesized to be critical for ECM assembly, and by extension, for heart development. The consequences of impaired hemocyte function in the embryo and during larval growth are unknown and are the focus of this research. Using Drosophila melanogaster as a model, I used genetic tools to manipulate hemocyte survival and motility to assess their role in ECM organization and structure around the heart. Concerted gene knockdown and confocal microscopy techniques were employed to evaluate the effects of altered hemocyte abundance and motility on hemocyte behaviour and resulting changes to the ECM. Here I provide evidence to support a role for hemocytes in the turnover of a vital ECM protein, the Type IV Collagen Viking. I also developed a novel protocol to photobleach and observe fluorescence recovery in intact, living larvae using confocal microscopy. Recovery of fluorescence of GFP tagged ECM is a measure of the rate of ECM protein turnover during development or growth. This novel technique has allowed for assessment of recovery of Viking-GFP after photobleaching in vivo, as a measue of Viking protein turnover at the cardiac ECM. This new technique can be employed to determine the turnover of other major ECM proteins. Combining hemocyte impairment with photobleaching provides the opportunity to observe innate protein turnover at the ECM in real time, both in normal and hemocyte-deprived matrices. Recovery of Viking-GFP fluorescence was also observed in hemocyte-deprived conditions. My findings reveal gradual recovery of Viking-GFP at the cardiac ECM in controls, and potentially slower recovery in hemocyte-impaired conditions. These observations suggest a role of hemocytes in ECM protein turnover. This work will help reveal the role of hemocytes in organizing the cardiac ECM and provides a novel technique for the in vivo assessment of ECM protein turnover. Ultimately, this research sheds light on how hemocyte function affects overall structure of the cardiac ECM and contributes to an enhanced understanding of how changes in this ECM influence predisposition to and progress of cardiac disease. / Thesis / Master of Science (MSc)
|
50 |
Controlling Curvature and Stiffness in Fibrous Environments Uncovers Force-Driven Processes and PhenotypesHernandez Padilla, Christian 22 August 2024 (has links)
In recent decades science has become an increasingly multidisciplinary field in which the lines that used to divide starkly different fields have blurred or disappeared completely. This work is a compendium of different angles focused at exploring disease progression of cancer biology through the perspective of mechanical engineering. We explore cancer through a holistic approach considering mechanistic, physical, genetic biology, biochemical, and immune cells to explore how the interplay with fiber networks can expand our understanding. We explored the physical interplay with biological processes of fibroblastic cells and show how these are critically regulated by forces that alter their ability to coil depends on fiber curvature and adhesion strength; thus, showing how cellular processes are driven by the balances of mechanical forces. Conversely, not all cell types are driven by the same factors, where we report that the structural features of migratory DCs enable them to be less influenced by the differences in fiber diameters, contrasting drastically what we previously reported on the other cell lines. Finally developing a novel composite nanofiber platform, we reported how some cancer cells are mechanistically influenced by the architecture of a substrate and thus resulting in completely different migratory responses that we have associated with key regulatory genes and responding completely differently when in the presence of clinically relevant molecular therapies. Overall, we investigated cancer biology through stiffness gradients, geometric influence through biophysics on myoblasts, and immune cell migration forces as a strong indicator of cell behavior. / Master of Science / Biology has historically been studied through chemistry and genetics, an approach that has produced incredible scientific discoveries such as vaccines and various therapies. Similarly, mechanical engineering has taken us to corners of the world that we never thought possible through the creation of machines, vehicles and the creation of new metal alloys. This research work is part of an emergent field of collaborative science which is paving the way to new ideas and the development of compound fields such as mechanobiology. Here we investigate how cells migrate through small rope-like environments that imitate the same fibers our cells can encounter in the body. We control the thickness, the arrangement, the orientation and the strength of these ropes to investigate how cells react to these environments, thus reporting on the new behaviors cells adopts in these conditions as well as their potential medical implications. Overall, we have developed new methods of studying cancer and other types of cells by tackling new questions using a mechanical perspective.
|
Page generated in 0.0486 seconds